Quoted Micro 3 November 2025

AQUIS STOCK EXCHANGE Digital assets investor KR1 (KR1) is planning a move to the Main Market. A prospectus has been published, and the switch is expected on 25 November. There are also plans to raise money from a placing programme of up to 125 million shares if it is agreed by shareholders at a general […]

Quoted Micro 15 September 2025

AQUIS STOCK EXCHANGE Newbury Racecourse (NYR) increased interim turnover 4% to £9.67m and the loss reduced to £150,000. Hospitality, hotel and nursery revenues all increased. Higher attendances improved core revenues as well. Changes in betting tax rates could hold back racing revenues. ProBiotix Health (PBX) increased interim revenues by one-third to £1.34m. This helped to […]

Quoted Micro 14 April 2025

AQUIS STOCK EXCHANGE BWA Group (BWAP) published an updated inferred mineral resource for the Dehane heavy mineral sands project in Cameroon of 4.2 million tonnes at 3.5% THM cut-off, comprising grades of ilmenite at 0.99%, kyanite at 1.54%, rutile at 0.13% and zircon at 0.11%. There are plans for a fundraising during this year to […]

Quoted Micro 2 September 2024

AQUIS STOCK EXCHANGE VSA Capital (VSA) revealed a strategic partnership with Drakewood Capital Management. This covers commodities trading, fund management and investment banking. This should provide a broader service for junior mining companies. Drakewood is subscribing £405,000 for VSA shares at 9p each and that was a 50% premium over the market price. Mark Thompson […]

Tekcapital #TEK – Portfolio Companies Update

Tekcapital Plc (AIM: TEK), the UK intellectual property investment group is pleased to provide a summary of latest developments across certain of its portfolio companies.  Belluscura  Belluscura plc (“Belluscura” AIM: BELL), announced on 16 August 2023 it has received purchase orders for over 6,500 of its next-generation DISCOV-R portable oxygen concentrator. This represents approximately US$15 […]

#TEK Tek Capital PLC investee co #BELL Belluscura PLC – Placing of Unsecured Convertible Loan Notes

Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, today announces that it has raised approximately $5.0 million (£4.1 million) through the conditional issue of a 10% Unsecured Convertible Loan Notes 2026 (the “Placing Loan Notes”) (the “Placing”). Dowgate Capital Limited (“Dowgate”) is acting as sole placing […]

#TEK TekCapital Plc investee co. #BELL Belluscura Plc – Year-end Trading Update

LONDON, U.K. AND PLANO, TX, U.S. (13 January 2023) Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen concentrator (“POC”) technology, provides a trading update for the year ended 31 December 2022. The Group is pleased to announce that it has made considerable progress this year. Since the launch of […]

Tekcapital #TEK investee company Belluscura #BELL receives certification to major ISO standard

Belluscura, a leading medical device developer focused on lightweight and portable oxygen enrichment technology, is pleased toannounce today that it has been certified as compliant with ISO standards for Quality Management (ISO 13485:2016), allowing for design, development, manufacture and distribution of its portable oxygen concentrators (POC) following an extensive audit process undertaken by leading global […]

Tekcapital #TEK investee company Belluscura #BELL – Half year results to June 2022 and new agreement with US distributor

Belluscura #BELL Half year results to June 2022 and new agreement with US distributor. Significant progress with best-in-class product launches, securing manufacturing capacity and expanding our market Financial highlights – record revenue ·      Group revenue of $0.6 million (H1 2021: $nil); a 34% increase over H2 2021. ·      Adjusted EBITDA of $5.1 million loss (H1 […]

Andrew Hore – Quoted Micro 31 May 2021

AQUIS STOCK EXCHANGE Pharma C Investments (PCIL) is a shell seeking to invest in medicinal cannabis sector-focused companies, particularly those that provide ancillary products and services to the sector, and it joined the Access segment on 26 May. The indication is that plant genetics, product testing, marketing, procurement services and cannabis consumption devices are areas […]